摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1r,3r,7e,17beta)-17-[(2r,3r)-3-Butyl-5-Ethyl-5-Hydroxyheptan-2-Yl]-2-Methylidene-9,10-Secoestra-5,7-Diene-1,3-Diol | 1608457-66-4

中文名称
——
中文别名
——
英文名称
(1r,3r,7e,17beta)-17-[(2r,3r)-3-Butyl-5-Ethyl-5-Hydroxyheptan-2-Yl]-2-Methylidene-9,10-Secoestra-5,7-Diene-1,3-Diol
英文别名
(1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R,3R)-3-butyl-5-ethyl-5-hydroxyheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-2-methylidenecyclohexane-1,3-diol
(1r,3r,7e,17beta)-17-[(2r,3r)-3-Butyl-5-Ethyl-5-Hydroxyheptan-2-Yl]-2-Methylidene-9,10-Secoestra-5,7-Diene-1,3-Diol化学式
CAS
1608457-66-4
化学式
C32H54O3
mdl
——
分子量
486.779
InChiKey
OILLQCLQUXHGBN-ZVBNMKQKSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    7.4
  • 重原子数:
    35
  • 可旋转键数:
    10
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.81
  • 拓扑面积:
    60.7
  • 氢给体数:
    3
  • 氢受体数:
    3

反应信息

  • 作为产物:
    描述:
    ethyl (2E)-4-[(1R,3R,7E,17β)-1,3-bis{[tert-butyl(dimethyl)silyl]oxy}-2-methylidene-9,10-secoestra-5,7-dien-17-yl]pent-2-enoate 在 copper(I) bromide dimethylsulfide complex 、 camphor-10-sulfonic acid 作用下, 以 四氢呋喃甲醇正己烷 为溶剂, 反应 8.75h, 生成 (1r,3r,7e,17beta)-17-[(2r,3r)-3-Butyl-5-Ethyl-5-Hydroxyheptan-2-Yl]-2-Methylidene-9,10-Secoestra-5,7-Diene-1,3-Diol
    参考文献:
    名称:
    A Mixed Population of Antagonist and Agonist Binding Conformers in a Single Crystal Explains Partial Agonism against Vitamin D Receptor: Active Vitamin D Analogues with 22R-Alkyl Group
    摘要:
    We are continuing to study the structural basis of vitamin D receptor (VDR) agonism and antagonism by using 22S-alkyl vitamin D analogues. Here we report the synthesis and biological evaluation of 22R-alkyl analogues and the X-ray crystallographic analysis of vitamin D receptor ligand-binding domain (VDR-LBD) complexed with a 22R-analogue. VDR-LBD complexed with the partial agonist 8a showed that 8a binds to VDR-LBD with two conformations, one of which is the antagonist/VDR-LBD complex structure and the other is the agonist/VDR-LBD complex structure. The results indicate that the partial agonist activity of 8a depends on the sum of antagonistic and agonistic activities caused by the antagonist and agonist binding conformers, respectively. The structural basis observed here must be applicable to the partial agonism of other ligand-dependent nuclear receptors. This is the first report describing the trapping of a conformational subset of the ligand and the nuclear receptor in a single crystal.
    DOI:
    10.1021/jm500392t
点击查看最新优质反应信息

文献信息

  • A Mixed Population of Antagonist and Agonist Binding Conformers in a Single Crystal Explains Partial Agonism against Vitamin D Receptor: Active Vitamin D Analogues with 22<i>R</i>-Alkyl Group
    作者:Yasuaki Anami、Toshimasa Itoh、Daichi Egawa、Nobuko Yoshimoto、Keiko Yamamoto
    DOI:10.1021/jm500392t
    日期:2014.5.22
    We are continuing to study the structural basis of vitamin D receptor (VDR) agonism and antagonism by using 22S-alkyl vitamin D analogues. Here we report the synthesis and biological evaluation of 22R-alkyl analogues and the X-ray crystallographic analysis of vitamin D receptor ligand-binding domain (VDR-LBD) complexed with a 22R-analogue. VDR-LBD complexed with the partial agonist 8a showed that 8a binds to VDR-LBD with two conformations, one of which is the antagonist/VDR-LBD complex structure and the other is the agonist/VDR-LBD complex structure. The results indicate that the partial agonist activity of 8a depends on the sum of antagonistic and agonistic activities caused by the antagonist and agonist binding conformers, respectively. The structural basis observed here must be applicable to the partial agonism of other ligand-dependent nuclear receptors. This is the first report describing the trapping of a conformational subset of the ligand and the nuclear receptor in a single crystal.
查看更多